Literature DB >> 11313983

Characterization of the promoter region of the viral interferon regulatory factor encoded by Kaposi's sarcoma-associated herpesvirus.

X P Wang1, Y J Zhang, J H Deng, H Y Pan, F C Zhou, E A Montalvo, S J Gao.   

Abstract

Viral interferon regulatory factor (vIRF) encoded by Kaposi's sarcoma-associated herpesvirus (KSHV) inhibits the expression of interferon-responsive genes, causes cellular transformation and transactivates KSHV genes. In the present study, we characterized the mRNA expression pattern of the vIRF gene and its promoter. A vIRF transcript of 1.7 kb in size was detected in low level in uninduced KSHV-infected cells and its expression was inducible by 12-O-tetradecanoylphorbol-13-acetate (TPA), sensitive to cycloheximide and resistant to phosphonoacetic acid. The transcription start site was mapped to 79 nt upstream of the ATG initiation site by 5'-RACE. Mutagenesis analysis identified a region between -56 and the transcription start site (+1) as the minimal promoter region that contains a functional TATA box at -27. A region between -337 and -125 contains a repressor domain negated by sequence from -991 to -499 in BCBL-1 cells, a region which was also identified to be responsive to TPA induction. These results demonstrate vIRF as a KSHV early gene, identify its promoter and define the promoter regions that contain regulatory elements controlling vIRF transcription.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313983     DOI: 10.1038/sj.onc.1204115

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Early and sustained expression of latent and host modulating genes in coordinated transcriptional program of KSHV productive primary infection of human primary endothelial cells.

Authors:  Seung Min Yoo; Fu-Chun Zhou; Feng-Chun Ye; Hong-Yi Pan; Shou-Jiang Gao
Journal:  Virology       Date:  2005-09-08       Impact factor: 3.616

Review 2.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

3.  Identification of a novel cellular transcriptional repressor interacting with the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus.

Authors:  Hong-Yi Pan; Yan-Jin Zhang; Xin-Ping Wang; Jian-Hong Deng; Fu-Chun Zhou; Shou-Jiang Gao
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

4.  An alternative Kaposi's sarcoma-associated herpesvirus replication program triggered by host cell apoptosis.

Authors:  Alka Prasad; Michael Lu; David M Lukac; Steven L Zeichner
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

5.  A cluster of transcripts encoded by KSHV ORF30-33 gene locus.

Authors:  Zhiqiang Bai; Fuchun Zhou; Xiufen Lei; Xinting Ma; Chun Lu; Shou-Jiang Gao
Journal:  Virus Genes       Date:  2011-12-17       Impact factor: 2.332

6.  Intracellular Kaposi's sarcoma-associated herpesvirus load determines early loss of immune synapse components.

Authors:  Laura A Adang; Costin Tomescu; Wai K Law; Dean H Kedes
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

7.  Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis.

Authors:  Fu-Chun Zhou; Yan-Jin Zhang; Jian-Hong Deng; Xin-Ping Wang; Hong-Yi Pan; Evelyn Hettler; Shou-Jiang Gao
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

8.  Short duration of elevated vIRF-1 expression during lytic replication of human herpesvirus 8 limits its ability to block antiviral responses induced by alpha interferon in BCBL-1 cells.

Authors:  Veronika P Pozharskaya; Laura L Weakland; James C Zimring; Laurie T Krug; Elizabeth R Unger; Andrew Neisch; Harish Joshi; Naoki Inoue; Margaret K Offermann
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA.

Authors:  Xiufen Lei; Zhiqiang Bai; Fengchun Ye; Jianping Xie; Chan-Gil Kim; Yufei Huang; Shou-Jiang Gao
Journal:  Nat Cell Biol       Date:  2010-01-17       Impact factor: 28.824

10.  The viral interferon regulatory factors of KSHV: immunosuppressors or oncogenes?

Authors:  Sarah R Jacobs; Blossom Damania
Journal:  Front Immunol       Date:  2011-06-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.